Hormonal therapy of prostatic carcinoma Is there a rationale for delayed treatment?
- 31 March 1986
- Vol. 27 (3) , 199-204
- https://doi.org/10.1016/0090-4295(86)90275-x
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancerThe Prostate, 1984
- Survival following orchiectomy for stage D adenocarcinoma of the prostateJournal of Surgical Oncology, 1984
- The Influence of Hormonal Therapy on Survival of Men with Advanced Prostatic CancerJournal of Urology, 1982
- Resolution of bony metastases after bilateral orchiectomy for carcinoma of prostateUrology, 1981
- Flow cytometric analysis of the response of the r3327-g rat prostatic adenocarcinoma to endocrine manipulationJournal of Surgical Oncology, 1981
- Prostatic Carcinoma Cured with Hormonal TreatmentScandinavian Journal of Urology and Nephrology, 1981
- Experience with Flutamide in Previously Untreated Patients With Advanced Prostatic CancerJournal of Urology, 1979
- Treatment of advanced cancer of prostate with megestrol acetateUrology, 1978
- Prediction of Prognosis for Prostatic Adenocarcinoma by Combined Histological Grading and Clinical StagingJournal of Urology, 1974
- The veterans administration cooperative urological research group's studies of cancer of the prostateCancer, 1973